Alveron Pharma Announces €5M Seed Extension Financing To Accelerate Breakthrough Therapy For Intracranial HaemorrhageGrace Crocker2024-12-09T14:20:07+00:00December 9th, 2024|BioCity Nottingham, Investment|
IsomAb Closes £7.5m Financing To Drive New Diabetic TreatmentSteve Jarvis2024-11-28T14:26:00+00:00February 21st, 2024|BioCity Nottingham, Investment, News|
Why A Sustainable Life Sciences Sector Is Fundamental To Climate MitigationAmy Cotterill2024-11-26T12:10:48+00:00October 6th, 2023|Article, BioCity Nottingham, Colworth Park, Hexagon Tower, Wilton Centre|
HistologiX Adds Visiopharm To Their Histopathology WorkflowVicky Coghlan2024-12-05T12:34:22+00:00June 5th, 2023|BioCity Nottingham|
MedTech Investment: How Pioneer Group Is Supporting The Game-Changers Of TomorrowAmy Cotterill2024-11-28T16:42:01+00:00May 23rd, 2023|Accelerator, BioCity Nottingham, Investment, MediCity Nottingham|
Drug Discovery Research Collaboration Announced By Sygnature Discovery And Daewoong PharmaVicky Coghlan2024-11-28T14:06:17+00:00April 24th, 2023|Article, BioCity Nottingham, News|
Life Science Accelerator Programme: How Cutting-Edge Companies Are Growing Organically At BioCity NottinghamAmy Cotterill2024-11-28T14:46:11+00:00April 17th, 2023|Accelerator, BioCity Nottingham, Investment, News|
Alveron Pharma Commences Clinical Trial Of New Intracranial Haemorrhage DrugVicky Coghlan2024-11-28T14:47:31+00:00March 31st, 2023|BioCity Nottingham, News|
Myconeos Innovate UK Smart Grant SuccessVicky Coghlan2023-03-28T14:48:14+01:00March 28th, 2023|BioCity Nottingham, News|
NanoSyrinx Joins Life Sciences Incubator In NottinghamAmy Cotterill2024-11-28T14:47:44+00:00March 27th, 2023|Accelerator, BioCity Nottingham, Investment, News|
